Compare ANL & MVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | ANL | MVO |
|---|---|---|
| Founded | 2004 | 2006 |
| Country | Cayman Islands | United States |
| Employees | N/A | N/A |
| Industry | | Oil & Gas Production |
| Sector | | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.0M | 49.9M |
| IPO Year | 2023 | N/A |
| Metric | ANL | MVO |
|---|---|---|
| Price | $1.46 | $1.30 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 28.5K | ★ 55.1K |
| Earning Date | 04-20-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 17.46% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.46 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $7.29 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.88 | $8.85 |
| 52 Week High | $2.99 | $13.95 |
| Indicator | ANL | MVO |
|---|---|---|
| Relative Strength Index (RSI) | 54.49 | 29.33 |
| Support Level | $0.88 | $1.18 |
| Resistance Level | $1.59 | $1.40 |
| Average True Range (ATR) | 0.17 | 0.14 |
| MACD | 0.02 | 0.15 |
| Stochastic Oscillator | 81.73 | 50.89 |
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.
MV Oil Trust is a statutory trust. Its underlying properties consist of MV Partners, LLC's (MV Partners) net interests in all of its oil and natural gas properties, which are located in the Mid-Continent region in the States of Kansas and Colorado. These properties include producing oil and gas wells.